Exane Derivatives’s Natural Order Acquisition Corp. Unit NOACU Stock Holding History

Exane Derivatives’s Portfolio NOACU Stock Details NOACU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$940K	Hold	95,000	–	–	0.54%	46
2022 Q1	$948K	Hold	95,000	–	–	0.27%	100
2021 Q4	$963K	Hold	95,000	–	–	0.23%	96
2021 Q3	$980K	Hold	95,000	–	–	0.24%	93
2021 Q2	$988K	Hold	95,000	–	–	0.22%	94
2021 Q1	$999K	Buy	95,000 +55,000	+138%	+$643K	0.29%	82
2020 Q4	$434K	Buy	+40,000	New	+$427K	0.13%	187

Other funds holding NOACU

Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Spartan Fund Management Toronto, Ontario, Canada $30M AUM 11.98% 1-Year Est. Return

Landscape Capital Management Englewood, New Jersey $1.54B AUM 30.95% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Sandia Investment Management Boston, Massachusetts $40.1M AUM 14.58% 1-Year Est. Return

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return

Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

Darrow Company Needham, Massachusetts $250M AUM 9.37% 1-Year Est. Return

Exane Derivatives's NOACU Position: Q2 2022 in Review

Exane Derivatives held its Natural Order Acquisition Corp. Unit (NOACU) position steady in Q2 2022 at 95,000 shares worth $940K. The position accounts for 0.54% of the portfolio, ranked #46.

Exane Derivatives first reported a position in NOACU in Q4 2020 and has held it in 7 quarters since. The position peaked at $999K in Q1 2021. 13 funds tracked by Wall St. Rank hold NOACU as of Q2 2022.

Exane Derivatives held 95,000 shares of Natural Order Acquisition Corp. Unit worth $940K as of Q2 2022.
Exane Derivatives left its Natural Order Acquisition Corp. Unit share count unchanged in Q2 2022.
Natural Order Acquisition Corp. Unit made up 0.54% of Exane Derivatives's portfolio in Q2 2022, its #46 holding.
Exane Derivatives first reported a position in Natural Order Acquisition Corp. Unit in Q4 2020 and has held it in 7 quarters since.
Exane Derivatives's Natural Order Acquisition Corp. Unit position peaked at $999K in Q1 2021.
13 funds tracked by Wall St. Rank held Natural Order Acquisition Corp. Unit as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.